561 related articles for article (PubMed ID: 29050360)
1. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.
Medrano RFV; Hunger A; Mendonça SA; Barbuto JAM; Strauss BE
Oncotarget; 2017 Sep; 8(41):71249-71284. PubMed ID: 29050360
[TBL] [Abstract][Full Text] [Related]
2. Induction and regulation of IFNs during viral infections.
Malmgaard L
J Interferon Cytokine Res; 2004 Aug; 24(8):439-54. PubMed ID: 15320958
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons and dendritic cells in cancer immunotherapy.
Sprooten J; Agostinis P; Garg AD
Int Rev Cell Mol Biol; 2019; 348():217-262. PubMed ID: 31810554
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.
Rizza P; Moretti F; Belardelli F
Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature.
Spaapen RM; Leung MY; Fuertes MB; Kline JP; Zhang L; Zheng Y; Fu YX; Luo X; Cohen KS; Gajewski TF
J Immunol; 2014 Oct; 193(8):4254-60. PubMed ID: 25217157
[TBL] [Abstract][Full Text] [Related]
6. The interferon system of teleost fish.
Robertsen B
Fish Shellfish Immunol; 2006 Feb; 20(2):172-91. PubMed ID: 15939626
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
8. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
9. The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils.
Pylaeva E; Lang S; Jablonska J
Front Immunol; 2016; 7():629. PubMed ID: 28066438
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox.
Nguyen KB; Cousens LP; Doughty LA; Pien GC; Durbin JE; Biron CA
Nat Immunol; 2000 Jul; 1(1):70-6. PubMed ID: 10881178
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma induces apoptosis in HL-60 cells through decreased Bcl-2 and increased Bak expression.
Zhou Y; Weyman CM; Liu H; Almasan A; Zhou A
J Interferon Cytokine Res; 2008 Feb; 28(2):65-72. PubMed ID: 18279102
[TBL] [Abstract][Full Text] [Related]
12. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.
Zitzmann K; Brand S; De Toni EN; Baehs S; Göke B; Meinecke J; Spöttl G; Meyer HH; Auernhammer CJ
Cancer Res; 2007 May; 67(10):5025-32. PubMed ID: 17510435
[TBL] [Abstract][Full Text] [Related]
13. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
14. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Choi EA; Lei H; Maron DJ; Wilson JM; Barsoum J; Fraker DL; El-Deiry WS; Spitz FR
Cancer Res; 2003 Sep; 63(17):5299-307. PubMed ID: 14500361
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
16. Interferons and their role In inflammation.
Tilg H; Kaser A
Curr Pharm Des; 1999 Oct; 5(10):771-85. PubMed ID: 10526087
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of type I interferons on cells of the immune system.
Hervas-Stubbs S; Perez-Gracia JL; Rouzaut A; Sanmamed MF; Le Bon A; Melero I
Clin Cancer Res; 2011 May; 17(9):2619-27. PubMed ID: 21372217
[TBL] [Abstract][Full Text] [Related]
18. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.
Nakahara N; Pollack IF; Storkus WJ; Wakabayashi T; Yoshida J; Okada H
Cancer Gene Ther; 2003 Jul; 10(7):549-58. PubMed ID: 12833135
[TBL] [Abstract][Full Text] [Related]
19. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
20. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
